Eye Optical Articles & Analysis
2 articles found
Currently, several siRNA drugs for rare diseases have been approved for marketing, such as: Patisiran (Hereditary trans thyroxine amyloidosis, ATTR) Exondys51 (Duchenne muscular dystrophy, DMD) Givosiran (Acute intermittent porphyria, AIP) Inclisiran (Hyperlipidemia) Tivanisiran (Dry eye syndrome, DES) QPI-1007 (Optic atrophy) SYL040012 (Glaucoma) QPI-1002 ...
This case study illustrates designing and fabricating silicone bolus using the Adaptiiv software solution. This flexible silicone bolus fabrication process was then compared to the fabrication process of a rigid 3D printed bolus to determine whether it yielded comparable or improved plan metrics for treating an inner canthus ...